| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.470 | 12.299 | 11.556 | 7.629 | 7.302 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 11.472 | 12.299 | 11.556 | 7.629 | 7.302 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 2.376 | 4.518 | 8.224 | 6.778 | 9.862 | 14.562 | 133 | 3.546 | 2.764 | 925 |
| Gross Profit/Loss - EUR | 9.095 | 7.781 | 3.332 | 850 | -2.559 | -14.562 | -133 | -3.546 | -2.764 | -925 |
| Net Profit/Loss - EUR | 8.752 | 7.412 | 2.985 | 621 | -2.873 | -14.562 | -133 | -3.546 | -2.764 | -925 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Upper.med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 678 | 20.109 | 14.533 | 10.411 | 4.068 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 6.710 | 2.007 | 2.933 | 7.333 | 10.406 | 257 | 320 | 192 | 4.068 | 3.647 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 751 | 1.513 | 799 | 580 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 5.960 | 494 | 2.134 | 6.753 | 10.406 | 257 | 320 | 192 | 4.068 | 3.647 |
| Shareholders Funds | 7.313 | 14.650 | 17.387 | 17.689 | 14.474 | -363 | -488 | -4.035 | -6.787 | -7.651 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 64 |
| Debts | 75 | 7.466 | 79 | 55 | 0 | 620 | 809 | 4.228 | 10.856 | 11.297 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Upper.med S.r.l.